Routine paediatric vaccine - Hepatitis A — Competitive Intelligence Brief

Routine paediatric vaccine - Hepatitis A (Routine paediatric vaccine - Hepatitis A) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: inactivated viral vaccine. Area: Immunology / Infectious Disease.

phase 3 inactivated viral vaccine Hepatitis A virus antigen Immunology / Infectious Disease Biologic

Target snapshot

Routine paediatric vaccine - Hepatitis A (Routine paediatric vaccine - Hepatitis A) — Sanofi Pasteur, a Sanofi Company. Hepatitis A vaccine stimulates the immune system to produce antibodies against hepatitis A virus, providing protection against infection.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Routine paediatric vaccine - Hepatitis A TARGET	Routine paediatric vaccine - Hepatitis A	Sanofi Pasteur, a Sanofi Company	phase 3	inactivated viral vaccine	Hepatitis A virus antigen
Comparator: VAQTA™	Comparator: VAQTA™	Merck Sharp & Dohme LLC	marketed	Inactivated viral vaccine	Hepatitis A virus antigen
Engerix-B and Twinrix	Engerix-B and Twinrix	St. Joseph's Health Care London	marketed	Vaccine	Hepatitis B surface antigen (HBsAg); Hepatitis A virus antigen
Healive+Healive	Healive+Healive	Sinovac Biotech Co., Ltd	marketed	Combination vaccine	Hepatitis A virus antigen; Hepatitis B surface antigen (HBsAg)
Havrix+Healive	Havrix+Healive	Sinovac Biotech Co., Ltd	marketed	Combination inactivated viral vaccine	Hepatitis A virus antigen; Hepatitis B surface antigen (HBsAg)
Havrix (HAV)	Havrix (HAV)	Pfizer	marketed	Inactivated viral vaccine	Hepatitis A virus antigen
Havrix Junior	Havrix Junior	GlaxoSmithKline	marketed	Inactivated viral vaccine	Hepatitis A virus antigen

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (inactivated viral vaccine class)

1. Sinovac Biotech Co., Ltd · 5 drugs in this class
2. Sinovac Research and Development Co., Ltd. · 2 drugs in this class
3. Sanofi Pasteur, a Sanofi Company · 2 drugs in this class
4. Federal University of Espirito Santo · 1 drug in this class
5. International Vaccine Institute · 1 drug in this class
6. MacroGenics · 1 drug in this class
7. Shandong Province Centers for Disease Control and Prevention · 1 drug in this class
8. Beijing Chaoyang District Centre for Disease Control and Prevention · 1 drug in this class
9. Zhejiang Provincial Center for Disease Control and Prevention · 1 drug in this class
10. Centers for Disease Control and Prevention · 1 drug in this class